Buy ($175)
Topics covered: The FDA Clamp-Down, The changing Pharmaceutical Business Model, Targeted Therapies in Oncology, Supplying unmet medical needs, Stem cell preservation, Phase III Trials, Pharmaceutical and Biotech partnerships, Oncology and Acute care, New uses for stalled drugs, Intracellular Signaling Pathways, Growing new blood vessels, Antisense Technology
or create an account with a social network.
or login using a social network
